bazedoxifene has been researched along with fluorouracil in 1 studies
| Studies (bazedoxifene) | Trials (bazedoxifene) | Recent Studies (post-2010) (bazedoxifene) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
|---|---|---|---|---|---|
| 307 | 69 | 249 | 45,562 | 9,307 | 14,663 |
| Protein | Taxonomy | bazedoxifene (IC50) | fluorouracil (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
| Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
| Aromatase | Homo sapiens (human) | 0.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Z; Li, S; Tian, J; Wang, X; Yang, J; Zhang, H; Zhang, L; Zhang, Z; Zhou, S | 1 |
1 other study(ies) available for bazedoxifene and fluorouracil
| Article | Year |
|---|---|
Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cytokine Receptor gp130; Down-Regulation; Female; Fluorouracil; Humans; Indoles; Interleukin-6; Mice; Mice, Nude; Neoplasm Invasiveness; Selective Estrogen Receptor Modulators; Signal Transduction; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2018 |